Track record · closed signal

AstraZeneca PLC (AZN) — closed signal from December 6, 2025

Target reached Published before the outcome was known, scored automatically when the window closed on March 6, 2026.

Predicted vs. what happened

AZN price · publication thesis → realized outcomesplit-adjusted
$178.48 Published $406.24 Target $194.22 Window close $210.50 Peak
$344.71 – $356.46Entry zone — fair-value band
$178.48Published — price the day we called it
$406.24Target — the price the thesis aimed for
$210.50Peak — highest point inside the window, not a realized return
$194.22Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 73 days.

Peak price
$210.50
peak on February 18, 2026 — not a realized return
Peak gain
+17.9%
peak, from the publication price
Window close
$194.22
end-of-window price, context only
Days to target
73
Window
December 6, 2025 – March 6, 2026

The thesis — published December 6, 2025

Predicted growth
+15%
over the measurement window
Target price
$406.24
the price the thesis aimed for
Entry zone
$344.71 – $356.46
the fair-value band we waited for
Price at publication
$178.48
published December 6, 2025
Confidence
61%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

AstraZeneca is a large, established drug company with recent news that could improve how it sells and licenses medicines globally. The deal to use Salesforce Agentforce Life Sciences and steady activity in China help make its future sales and pipeline income more likely. The stock looks oversold now, so a price rebound may happen soon, but underlying business strength is steady rather than exceptional.

Primary drivers

  • Overall score is a little better than the market and sentiment is fairly strong.
  • Deal to use Salesforce Agentforce Life Sciences improves global sales engagement.
  • China licensing activity and oncology focus create diversified future revenue.
  • Recent oversold price action could allow a near-term rebound, fundamentals are average.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.